Letter to Editor

Cancer and Artificial Intelligence

Volume: 5 Number: 2 June 14, 2024
EN TR

Cancer and Artificial Intelligence

Abstract

Cancer is a multifactorial group of diseases that are known to affect human life with incidence and mortality rates. Artificial Intelligence and the development of new strategies in cancer treatment are of great importance in helping physicians apply optimized treatment tailored to the patient, overcoming both physical and psychological difficulties, and preventing the recurrence and spread of the disease. Thanks to the field of health and Artificial Intelligence, which are integrated with current developments in coordination with each other, great advances have been made and continue to be made in the diagnosis, treatment and prognosis of cancer, one of the major problems of our age.

Keywords

References

  1. 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209-249.
  2. 2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.
  3. 3. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett. 2020;471:61-71.
  4. 4. Hu, C., Liu, X., Zeng, Y. et al. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenet, 2021; 13, 166.
  5. 5. Wong D, Yip S. Machine learning classifies cancer. Nature. 2018; 555(7697):446-447.
  6. 6. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2014;13:8-17.

Details

Primary Language

English

Subjects

Cancer Diagnosis, Cancer Therapy (Excl. Chemotherapy and Radiation Therapy), Predictive and Prognostic Markers

Journal Section

Letter to Editor

Early Pub Date

July 4, 2024

Publication Date

June 14, 2024

Submission Date

May 11, 2024

Acceptance Date

June 13, 2024

Published in Issue

Year 2024 Volume: 5 Number: 2

APA
Tutar, L. (2024). Cancer and Artificial Intelligence. Experimental and Applied Medical Science, 5(2), 93-94. https://doi.org/10.46871/eams.1482458
AMA
1.Tutar L. Cancer and Artificial Intelligence. Exp Appl Med Sci. 2024;5(2):93-94. doi:10.46871/eams.1482458
Chicago
Tutar, Leyla. 2024. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science 5 (2): 93-94. https://doi.org/10.46871/eams.1482458.
EndNote
Tutar L (June 1, 2024) Cancer and Artificial Intelligence. Experimental and Applied Medical Science 5 2 93–94.
IEEE
[1]L. Tutar, “Cancer and Artificial Intelligence”, Exp Appl Med Sci, vol. 5, no. 2, pp. 93–94, June 2024, doi: 10.46871/eams.1482458.
ISNAD
Tutar, Leyla. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science 5/2 (June 1, 2024): 93-94. https://doi.org/10.46871/eams.1482458.
JAMA
1.Tutar L. Cancer and Artificial Intelligence. Exp Appl Med Sci. 2024;5:93–94.
MLA
Tutar, Leyla. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science, vol. 5, no. 2, June 2024, pp. 93-94, doi:10.46871/eams.1482458.
Vancouver
1.Leyla Tutar. Cancer and Artificial Intelligence. Exp Appl Med Sci. 2024 Jun. 1;5(2):93-4. doi:10.46871/eams.1482458

    22718              20542      20690    20805   21108       22245 

22392     22717